Signpath pharma
WebMay 20, 2015 · SignPath is a clinical stage biotechnology company founded in May 2006 to develop synthesized proprietary formulations of curcumin, a naturally occurring compound found in the root of the Curcuma longa Linn (turmeric) plant, for applications in human diseases Good Manufacturing Practice (GMP) synthesis renders the curcumin active … WebSignPath Pharma Inc. Raises $235k in Series A led by Undisclosed Investor. Investment . 12/8/17 . $235K . SEC Form D. launch Source. SignPath Pharma Inc. Raises $245k in Series A from Undisclosed Investor. Investment . 7/15/16 . $245K . SEC form D. launch Source. SignPath Pharma Inc. Raises $2.4M in Series A from Undisclosed Investor.
Signpath pharma
Did you know?
WebPipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by SignPath Pharma Private Ltd WebSignpath Pharma is a clinical-stage company with a drug development platform that creates heart-safe drugs. It is based in Sandy, Utah. Headquarters Location. 7984 South 1300 East . Sandy, Utah, 84094, United States. Suggest an edit. Missing: Signpath Pharma's Product Demo & Case Studies.
WebFind company research, competitor information, contact details & financial data for Signpath Pharma, Inc. of Sandy, UT. Get the latest business insights from Dun & Bradstreet. WebSignPath Pharma Inc operates as a biotechnology company. The Company researches curcumin, a compound that occurs in the tumeric plant, as a treatment for malignant diseases. SignPath researches ...
WebSignPath Pharma, Inc. is a company that provides Pharmacy and Therapeutics, Curcumin, Curcuminoid and more. SignPath Pharma, Inc. is headquartered in United States Pennsylvania. SignPath Pharma, Inc. was founded in 2006. SignPath Pharma, Inc. has a total of 176 patents and 1 literature. WebSignPath Pharma Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14062024 Prices from USD $250. SummarySignPath Pharma Inc SignPath is a …
WebSignPath Pharma Inc. Quarterly Report on Form 10-Q. Period Ended March 10, 2010 . Table of Contents . Page. PART I . FINANCIAL INFORMATION . Item 1. Financial Statements: Condensed Balance Sheets as of March 31, 2010 (unaudited) and December 31, …
Websignpath pharma inc. 6,161,448 Shares of common stock This prospectus relates to the public offering of up to 6,161,448 shares of our common stock consisting of 1,507,500 shares issued to seventeen (17) retail accredited investors in a bridge financing and 4,653,948 shares issuable upon conversion and exercise of securities sold to 33 different … hospitality education awardsWebMar 28, 2024 · 215-538-9996 Sign Path Pharma Inc - whitepages.com. View Sign Path Pharma Inc's address, public records, background check, and more for 2155389996 with Whitepages reverse phone lookup - know who is calling from 215-538-9996.. SignPath Pharma, Inc. - Law Insider. 215-538-9996.Sample Contracts ... SignPath Pharma Inc. (the … psychocillibinWebSignPath Pharma is a biotechnology company. It develops products to treat cancer and mitigate drug-induced cardiac arrhythmia, which is a common side effect of many drugs, … psychocognitionWebAcepodia’s gamma delta (γδ)2 T cell program harnesses the unique properties of γδ2 T cells to develop a new class of off-the-shelf allogeneic cell therapies for the treatment of cancer. γδ2 T cells have characteristics of both the innate and adaptive immune systems that make them an ideal chassis for the development of cell therapies. hospitality education and career essayWebSignPath Pharma Inc. 105 followers on LinkedIn. SignPath Pharma (www.signpathpharma.com) is a clinical stage biotechnology company. SignPath Pharma (www.signpathpharma.com) is a clinical stage biotechnology company (Delaware C Corp.) founded in 2006. Currently, SignPath is actively developing products to treat cancer and … psychocrisispsychocybernetically defWebJun 22, 2009 · THIS AGREEMENT (“Agreement”), effective January 30, 2008 (the "Effective Date"), is by and between Sign Path Pharmaceuticals, Inc., a company incorporated in the State of Delaware and having its office at Office at 45 Broadway 2nd Floor New York, NY 10006, USA (“CLIENT”) and BROOKWOOD PHARMACEUTICALS, INC having a principal … psychodelic arnart mugs